Ablatus Therapeutics Limited
Private Limited Company · Leeds
Creditors Voluntary Liquidation (CVL)United KingdomIncorporated 2015Private Limited Company
Ownership evidence
Reported ownership and control rights in this business, with source dates.
Reported ownership & control
0 without an end date · 4 ceasedNo control records without an end date are available. This alone does not establish who owns or controls the company.
Show 4 ceased records
Mercia Asset Management PlcCorporate
Firm-related control: Shares: over 25%, up to 50%Significant influence or control
Notified 2019-12-03 · Ceased 2024-01-11
Source record 122479066Nvm Private Equity LlpCorporate
Significant influence or control
Notified 2018-04-19 · Ceased 2019-12-02
Source record 125214507Health Enterprise East LtdCorporate
Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%
Notified 2016-04-06 · Ceased 2017-10-11
Source record 121544391Shares: over 25%, up to 50%Voting rights: over 25%, up to 50%
Notified 2016-04-06 · Ceased 2017-10-11
Source record 121734075People behind the business
Current appointments and the wider business interests of each person.
Appointments
4 current · 3 historicalMF
Marcus FlatherCurrent director
Appointed 2016-06-29 · 10 yrs · University Professor & Consultant Cardio
Show 3 historical appointments
DL
David LewisResigned director
Resigned 2021-08-10 · Chief Executive
WA
William AllanResigned director
Resigned 2016-05-23 · 5 yrs · Executive
DB
David BrooksResigned director
Resigned 2015-10-07 · 4 yrs · Medical Research Professional
Board profile
- People with appointments
- 4
- Directors assessed
- 4
- Median age
- 54
- Under 35
- 0
- 65 and over
- 1
- Disqualified match
- None active